CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SLDB — Solid Biosciences Inc.
CIK 884546
SAN FRANCISCO, CA
Position in SLDB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,441,565
+$1,284,309 QoQ
Shares Held
244,401
+52.1% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 155 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLDB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. SLDB ranks #173 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in SLDB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,441,565 | 244,401 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,157,256 | 160,730 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $911,068 | 161,537 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $999,904 | 162,059 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,027,930 | 211,074 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $253,845 | 68,607 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $253,548 | 63,387 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $441,807 | 63,387 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $359,404 | 63,387 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $136,876 | 10,276 | Shares | Sole | 2024-05-09 | |
| 2023-03-31 | $47,400 | 10,000 | Shares | Sole | 2023-05-12 | |
| 2022-03-31 | $151,686 | 126,405 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $264,139 | 150,937 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $360,739 | 150,937 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $552,429 | 150,937 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $396,406 | 71,683 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $445,302 | 58,747 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $108,148 | 53,275 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $315,877 | 107,808 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $213,142 | 89,181 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||